Eslami, Seyyed Majid, et al. “Does Evolocumab, As a PCSK9 Inhibitor, Ameliorate the Lipid Profile in Familial Hypercholesterolemia Patients? A Meta-Analysis of Randomized Controlled Trials”. Journal of Pharmacy & Pharmaceutical Sciences, vol. 20, Apr. 2017, pp. 81-96, doi:10.18433/J36C8N.